These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 29573235

  • 21. Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma.
    Cho HJ, Baek GO, Seo CW, Ahn HR, Sung S, Son JA, Kim SS, Cho SW, Jang JW, Nam SW, Cheong JY, Eun JW.
    Cancer Med; 2020 Aug; 9(15):5459-5472. PubMed ID: 32537885
    [Abstract] [Full Text] [Related]

  • 22. The Predictive Efficacy of Serum Exosomal microRNA-122 and microRNA-148a for Hepatocellular Carcinoma Based on Smart Healthcare.
    Deng P, Li M, Wu Y.
    J Healthc Eng; 2022 Aug; 2022():5914541. PubMed ID: 35028121
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Potential biomarkers in NASH-induced liver cirrhosis with hepatocellular carcinoma: A preliminary work on roles of exosomal miR-182, miR-301a, and miR-373.
    Muhammad Yusuf AN, Raja Ali RA, Muhammad Nawawi KN, Mokhtar NM.
    Malays J Pathol; 2020 Dec; 42(3):377-384. PubMed ID: 33361718
    [Abstract] [Full Text] [Related]

  • 27. Integrated Predictors by Propensity Scoring With Tumor Markers and Plasma Levels of microRNA-21-5p, IL-17, and IL-10 Complement Early Detection of Hepatocellular Carcinoma in Patients With Liver Cirrhosis.
    Machida M, Ambo M, Mishina R, Hada N, Tachibana F, Yamashita M, Konda A, Tsuji K.
    Technol Cancer Res Treat; 2023 Dec; 22():15330338231212084. PubMed ID: 37960842
    [Abstract] [Full Text] [Related]

  • 28. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma.
    Wang Z, Gao P, Sun W, Rehman AU, Jiang J, Xu S, Xue C, Zhu C, Qin X.
    Front Endocrinol (Lausanne); 2023 Dec; 14():938102. PubMed ID: 36793272
    [Abstract] [Full Text] [Related]

  • 29. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma.
    Li J, Jin B, Wang T, Li W, Wang Z, Zhang H, Song Y, Li N.
    Cancer Biomark; 2019 Dec; 26(4):501-512. PubMed ID: 31658041
    [Abstract] [Full Text] [Related]

  • 30. Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma.
    Xue X, Zhao Y, Wang X, Qin L, Hu R.
    J Cell Biochem; 2019 Jan; 120(1):135-142. PubMed ID: 30238497
    [Abstract] [Full Text] [Related]

  • 31. Clinical value of LHPP-associated microRNAs combined with protein induced by vitamin K deficiency or antagonist-II in the diagnosis of alpha-fetoprotein-negative hepatocellular carcinoma.
    Tian Z, Yu T, Wei H, Ning N.
    J Clin Lab Anal; 2020 Feb; 34(2):e23071. PubMed ID: 31693242
    [Abstract] [Full Text] [Related]

  • 32. Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study.
    Liu D, Luo Y, Chen L, Chen L, Zuo D, Li Y, Zhang X, Wu J, Xi Q, Li G, Qi L, Yue X, Zhang X, Sun Z, Zhang N, Song T, Lu W, Guo H.
    Cancer Biol Med; 2021 Feb 15; 18(1):256-270. PubMed ID: 33628599
    [Abstract] [Full Text] [Related]

  • 33. A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma.
    Huang J, Zheng Y, Xiao X, Liu C, Lin J, Zheng S, Yang B, Ou Q.
    Dis Markers; 2020 Feb 15; 2020():5417598. PubMed ID: 32733618
    [Abstract] [Full Text] [Related]

  • 34. Serum exosomal hnRNPH1 mRNA as a novel marker for hepatocellular carcinoma.
    Xu H, Dong X, Chen Y, Wang X.
    Clin Chem Lab Med; 2018 Feb 23; 56(3):479-484. PubMed ID: 29252188
    [Abstract] [Full Text] [Related]

  • 35. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
    Ji J, Wang H, Li Y, Zheng L, Yin Y, Zou Z, Zhou F, Zhou W, Shen F, Gao C.
    PLoS One; 2016 Feb 23; 11(4):e0153227. PubMed ID: 27070780
    [Abstract] [Full Text] [Related]

  • 36. Assessment of miR-212 and Other Biomarkers in the Diagnosis and Treatment of HBV-infection-related Liver Diseases.
    Zhang Y, Xi H, Nie X, Zhang P, Lan N, Lu Y, Liu J, Yuan W.
    Curr Drug Metab; 2019 Feb 23; 20(10):785-798. PubMed ID: 31608838
    [Abstract] [Full Text] [Related]

  • 37. Expression and significance of microRNA-183 in hepatocellular carcinoma.
    Liang Z, Gao Y, Shi W, Zhai D, Li S, Jing L, Guo H, Liu T, Wang Y, Du Z.
    ScientificWorldJournal; 2013 Feb 23; 2013():381874. PubMed ID: 24222732
    [Abstract] [Full Text] [Related]

  • 38. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    El-Abd NE, Fawzy NA, El-Sheikh SM, Soliman ME.
    Mol Diagn Ther; 2015 Aug 23; 19(4):213-20. PubMed ID: 26133725
    [Abstract] [Full Text] [Related]

  • 39. miR-224 is an early-stage biomarker of hepatocellular carcinoma with miR-224 and miR-125b as prognostic biomarkers.
    Yang L, Wei C, Li Y, He X, He M.
    Biomark Med; 2020 Oct 23; 14(15):1485-1500. PubMed ID: 33155836
    [Abstract] [Full Text] [Related]

  • 40. Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC.
    Fornari F, Ferracin M, Trerè D, Milazzo M, Marinelli S, Galassi M, Venerandi L, Pollutri D, Patrizi C, Borghi A, Foschi FG, Stefanini GF, Negrini M, Bolondi L, Gramantieri L.
    PLoS One; 2015 Oct 23; 10(10):e0141448. PubMed ID: 26509672
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.